春立医疗
(688236)
| 流通市值：39.54亿 | | | 总市值：52.59亿 |
| 流通股本：2.88亿 | | | 总股本：3.84亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 417,104,217.14 | 216,972,373.23 | 1,045,766,405.34 | 756,093,897.4 |
| 营业收入 | 417,104,217.14 | 216,972,373.23 | 1,045,766,405.34 | 756,093,897.4 |
| 二、营业总成本 | 286,007,552.15 | 152,107,504.3 | 722,853,785.21 | 515,865,735.32 |
| 营业成本 | 147,785,747.32 | 73,197,939.64 | 355,128,323.72 | 247,450,780.09 |
| 税金及附加 | 4,246,542.01 | 2,618,875.54 | 10,178,302.28 | 6,867,479.82 |
| 销售费用 | 65,783,090.88 | 39,159,180.28 | 198,182,667.23 | 146,195,182.01 |
| 管理费用 | 19,561,228.97 | 11,140,244.15 | 52,257,644.14 | 38,603,081.68 |
| 研发费用 | 47,226,656.71 | 26,538,690.18 | 118,503,200.2 | 86,472,598.27 |
| 财务费用 | 1,404,286.26 | -547,425.49 | -11,396,352.36 | -9,723,386.55 |
| 其中:利息费用 | 76,746.69 | - | 39,150.21 | 14,188.8 |
| 其中:利息收入 | 7,282,885.42 | 3,599,755.52 | 15,278,391.56 | 10,658,846.31 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 3,648,527.39 | 2,337,534.25 | 8,742,663 | 7,078,936.97 |
| 加:投资收益 | 2,818,027.41 | - | 6,315,413.45 | 3,217,026.86 |
| 资产处置收益 | - | - | 3,848.03 | 3,848.03 |
| 资产减值损失(新) | -6,043,562.98 | -1,192,598.77 | -37,239,267.09 | -32,062,823.41 |
| 信用减值损失(新) | -820,156.72 | -248,050.73 | -9,700,984.89 | -13,646,674.5 |
| 其他收益 | 4,390,159.68 | 2,286,983.35 | 11,210,787.3 | 6,909,455.54 |
| 四、营业利润 | 135,089,659.77 | 68,048,737.03 | 302,245,079.93 | 211,727,931.57 |
| 加:营业外收入 | 160,577.65 | 1,967.79 | 204,535.55 | 195,880.52 |
| 减:营业外支出 | 1,792,993.29 | 36,134.02 | 737,901.89 | 135,115.14 |
| 五、利润总额 | 133,457,244.13 | 68,014,570.8 | 301,711,713.59 | 211,788,696.95 |
| 减:所得税费用 | 13,518,291.91 | 6,333,487.03 | 29,086,594.22 | 20,176,273.09 |
| 六、净利润 | 119,938,952.22 | 61,681,083.77 | 272,625,119.37 | 191,612,423.86 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 119,938,952.22 | 61,681,083.77 | 272,625,119.37 | 191,612,423.86 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 119,957,018.06 | 61,710,990.86 | 272,542,347.59 | 191,531,404.47 |
| 少数股东损益 | -18,065.84 | -29,907.09 | 82,771.78 | 81,019.39 |
| 扣除非经常损益后的净利润 | 114,147,628.46 | 58,869,012.49 | 255,525,502.91 | 180,704,056.22 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.31 | 0.16 | 0.71 | 0.5 |
| (二)稀释每股收益 | 0.31 | 0.16 | 0.71 | 0.5 |
| 九、综合收益总额 | 119,938,952.22 | 61,681,083.77 | 272,625,119.37 | 191,612,423.86 |
| 归属于母公司股东的综合收益总额 | 119,957,018.06 | 61,710,990.86 | 272,542,347.59 | 191,531,404.47 |
| 归属于少数股东的综合收益总额 | -18,065.84 | -29,907.09 | 82,771.78 | 81,019.39 |
| 公告日期 | 2026-08-29 | 2026-04-30 | 2026-03-31 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |